Cisatracurium Dosing Requirements in COVID-19 Compared to Non-COVID-19 Patients
- PMID: 34674581
- PMCID: PMC10189524
- DOI: 10.1177/08971900211052835
Cisatracurium Dosing Requirements in COVID-19 Compared to Non-COVID-19 Patients
References
-
- WHO Guideline Review Committee . Clinical Management of severe Acute Respiratory Infection When COVID-19 Disease is Suspected. WHO Iterim Guidance; 2020; 1-19.
-
- Poston JT, Patel BK, Davis AM. Management of critically ill adults with COVID-19. J Am Med Assoc. 2020;323(18):1839-1841. - PubMed
-
- Papazian L, Forel J-M, Gacouin A, et al.. Neuromuscular blockers in early acute respiratory distress syndrome. NEJM. 2010;363(12):1107-1116. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical